An open-label phase 1/2 study of DCC-3009 monotherapy in patients with advanced gastrointestinal stromal tumor.

Authors: Sreenivasa R. Chandana, Suzanne George, Ping Chi, Scott H. Okuno, Steven Attia, Alessandra Maleddu, Jonathan C. Trent, Adam Burgoyne, Vicki Leigh Keedy, Vandy Black, Bo King, Anna Papinska, Elma Feric Bojic, Ying Yuan, Frederic J. Reu, Matthew L. Sherman, Michael S. Gordon

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps11580

Source: Full article

---

Abstract

TPS11580